GLP-1R agonists in obesity management GLP-1R agonists, such as semaglutide, liraglutide, and tirzepatide, have gained prominence in the treatment of obesity
In these patients, doctors may monitor blood sugar, HbA1c, kidney function, eye health, and the risk of hypoglycaemia, especially if insulin or sulfonylureas are also used
These totals encompass multiple experimental groups undergoing OGTTs: i) WD and RD cannulated mice OB-infused with GLP-1, Ex4, Ex9 or vehicle [combined with IP injections of either Ex4 (3 g/kg), the 2 -AR agonist UK14304 (Bio-Techne
The team then showed that mice whose gut microbiota had been depleted using broad-spectrum antibiotics did not experience liraglutides antidepressant effects, pointing to a key role for the microorganisms in the gut